Skip to content
Disclosery

Sands Capital Alternatives, LLC

Follow

13F filer, CIK 1846444, ARLINGTON, VA

Sands Capital Alternatives, LLC reported $456,415,766 across 20 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-13. Its ten largest share positions make up 90.19% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001846444-25-000022

Period
2025-09-30
Reported value
$456M
Holdings
20
Top 10 weight
90.19%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IOTadded+160,429$5.98M
FIGnew+18,286$948K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DASHreduced-291,060-$79.2M
CPNGreduced-54,025-$1.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001846444-25-000022, largest first. % of portfolio is the value over $456,415,766, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,498,802 shares; 2024Q4: 7,021,159 shares; 2025Q1: 7,164,355 shares; 2025Q2: 7,175,434 shares; 2025Q3: 7,175,434 shares 7,175,434$115M25.17%0Timeline
KVYOKLAVIYO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,515,325 shares; 2024Q4: 3,470,694 shares; 2025Q1: 3,443,515 shares; 2025Q2: 3,515,065 shares; 2025Q3: 3,515,065 shares 3,515,065$97.3M21.33%0Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 3,103,782 shares; 2025Q2: 3,570,113 shares; 2025Q3: 3,570,113 shares 3,570,113$70.9M15.54%0Timeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,931 shares; 2024Q4: 924,712 shares; 2025Q1: 843,476 shares; 2025Q2: 849,031 shares; 2025Q3: 795,006 shares 795,006$25.6M5.61%-54,025Timeline
DASHDOORDASH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 423,338 shares; 2024Q4: 407,343 shares; 2025Q1: 380,704 shares; 2025Q2: 381,202 shares; 2025Q3: 90,142 shares 90,142$24.5M5.37%-291,060Timeline
IOTSAMSARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,172 shares; 2024Q4: 198,690 shares; 2025Q1: 253,432 shares; 2025Q2: 438,485 shares; 2025Q3: 598,914 shares 598,914$22.3M4.89%+160,429Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 10,950,000 shares; 2025Q1: 10,950,000 shares; 2025Q2: 10,950,000 shares; 2025Q3: 10,950,000 shares 10,950,000$17.7M3.89%0Timeline
DDOGDATADOG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,406 shares; 2024Q4: 97,788 shares; 2025Q1: 117,930 shares; 2025Q2: 118,707 shares; 2025Q3: 118,707 shares 118,707$16.9M3.7%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 48,278 shares; 2025Q1: 49,908 shares; 2025Q2: 58,336 shares; 2025Q3: 58,336 shares 58,336$11.3M2.48%0Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 170,000 shares; 2024Q4: 170,000 shares; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares; 2025Q3: 170,000 shares 170,000$10.1M2.21%0Timeline
CRWDCROWDSTRIKE HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 221 shares; 2024Q4: 17,100 shares; 2025Q1: 15,560 shares; 2025Q2: 15,615 shares; 2025Q3: 15,615 shares 15,615$7.66M1.68%0Timeline
SNOWSNOWFLAKE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,304 shares; 2024Q4: 39,007 shares; 2025Q1: 26,828 shares; 2025Q2: 27,005 shares; 2025Q3: 27,005 shares 27,005$6.09M1.33%0Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,417,075 shares; 2024Q4: 3,417,075 shares; 2025Q1: 3,417,075 shares; 2025Q2: 3,417,075 shares; 2025Q3: 3,417,075 shares 3,417,075$5.84M1.28%0Timeline
TOSTTOAST INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,453 shares; 2024Q4: 231,530 shares; 2025Q1: 210,611 shares; 2025Q2: 156,604 shares; 2025Q3: 156,604 shares 156,604$5.72M1.25%0Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 481,770 shares; 2024Q4: 481,770 shares; 2025Q1: 481,770 shares; 2025Q2: 481,770 shares; 2025Q3: 481,770 shares 481,770$5.63M1.23%0Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,086,353 shares; 2024Q4: 786,353 shares; 2025Q1: 786,353 shares; 2025Q2: 786,353 shares; 2025Q3: 786,353 shares 786,353$4.62M1.01%0Timeline
ACRVACRIVON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,122,605 shares; 2024Q4: 2,122,605 shares; 2025Q1: 2,122,605 shares; 2025Q2: 2,122,605 shares; 2025Q3: 2,122,605 shares 2,122,605$3.84M0.84%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 724,873 shares; 2024Q4: 724,873 shares; 2025Q1: 724,873 shares; 2025Q2: 724,873 shares; 2025Q3: 724,873 shares 724,873$2.37M0.52%0Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 405,837 shares; 2024Q4: 405,837 shares; 2025Q1: 405,837 shares; 2025Q2: 405,837 shares; 2025Q3: 405,837 shares 405,837$2.07M0.45%0Timeline
FIGFIGMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,286 shares 18,286$948K0.21%newTimeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001846444-25-000022 base2025-11-13acceptance time not in the bulk data set